Skip to main navigation

Search for:

Live - Top Menu

Clinical Trials
Investors & Media
Careers
Contact Us

Main navigation

Our Focus
Our Research
Our Medicine
Our Story

Home > Investors & Media > Press Releases

Investors & Media

Shareholder Tools

Email Alerts
Download Library
RSS
Print
Share

Facebook
LinkedIn
Twitter

Press Releases

Press Releases

Items Per Page

Year

May 16, 2006

Intercept Pharmaceuticals Closes $41 Million Equity Financing

Company Announces Lead Compound INT-747 Appears Well Tolerated in Phase 1 Study

Read More

May 04, 2005

Intercept Pharmaceuticals Announces Closing Of New Financing Round

Company to Present at Rodman & Renshaw Global Healthcare Conference

Read More

Oct 26, 2004

Liver And Metabolic Disease Company Intercept Pharmaceuticals To Present At Rodman & Renshaw Healthcare Conference

Company Also to Present Two Studies at The Liver Meeting™ Supporting Rationale

Read More

Aug 12, 2004

Intercept Pharmaceuticals Announces Publication Of Study Demonstrating Its Lead Compound Can Reverse Liver Fibrosis

Read More

Pagination

First page
Previous page
…
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Current page 32

Investors & Media

Shareholder Tools

Email Alerts
Download Library
RSS
Print
Share

Facebook
LinkedIn
Twitter

Live - Footer Menu

Privacy Policy
Privacy Shield Policy
Corporate Compliance
Terms of Use
Contact Us
Cookie Preferences

305 Madison Avenue|Morristown, NJ 07960|T: 844-782-ICPT

© 2023 Intercept Pharmaceuticals, Inc.